A retrospective study demonstrated that GLP-1 receptor agonist use before pregnancy corresponded with lower risks for ...

The PRAC still has another safety review on the go for the GLP-1 class, however ... taking them for signs of emerging or worsening depression. The labels for diabetes therapies Ozempic and ...

RAs, originally for diabetes, may impact brain health, finding potential benefits for dementia and addiction but inconsistent ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

GLP-1 weight loss drugs like Ozempic and Wegovy are popular with people who want to lose weight. However, there is another ...

The Federal Drug Administration last month approved Journavx, a new kind of non-addictive pain medication. Doctors say ...

Learn about the Make America Health Again Commission, investigating potential over-utilization of medications for depression, weight loss, and ADHD.

The weight of being a Hollywood star can take a toll on a person’s weight.In an industry obsessed with physical appearance, a ...

A 52-year-old man has knocked his decade-long cocaine addiction on the head after receiving weight-loss injections. The jab ...

GLP-1 drugs — which include Ozempic and its sister ... cancer and mental health conditions like depression and anxiety, Hurtado Andrade adds. “Keeping in mind that obesity is at the core ...

Persistently high rates of both type 1 and 2 diabetes as well as racial health disparities are indicators of lingering gaps in care for Indigenous communities.

GLP-1 receptor agonists can reduce the risk of heart attack and stroke by 20% in just 1 year. Jake Goodman, MD, MBA: One ...